https://www.selleckchem.com/pr....oducts/way-100635.ht
Sixteen were outpatients, 2 inpatients. Thirteen (81.25%) of the 16 outpatients were successfully treated with MA via SBCT and did not require admission. Twelve (75%) of these 13 had SBCT removed, 1 patient was discharged with SBCT and removed in 24 hours. Of the 18 patients requiring intervention, 13 (72.2%) were successfully treated with MA via SBCT enabling removal of SBCT. No patient required reintervention. MA via SBCT represents a safe and viable management approach of TBBX-IP promoting earlier SBCT removal and decreased hospit
Like
Comment
Share
